Cholesterol: enhancing stability and efficacy in lipid-based drug delivery
Download our latest whitepaper to learn how cholesterol can enhance stability and efficacy in lipid-based drug delivery.
As versatile formulations with a range of administration routes, lipid based drug delivery systems (LBBDS) have gained significant attention in pharmaceutical research. Offering a range of benefits including API solubility and bioavailability, LBBDS can be tailored to meet your formulation requirements. Cholesterol is a key component of LBDDS, providing structural support, in addition to such as benefits such as enhanced gene transfection.
Whitepaper: Cholesterol - enhancing stability and efficacy in lipid-based drug delivery
1.1 MB
Nucleic Acid Delivery
We develop and manufacture innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics
Innovative lipids for your nucleic acid delivery research
Lipid-based therapeutic delivery systems have been evolving for many years. From delivering naked mRNA, to using liposomes, and now lipid nanoparticles,
